Ufp Technologies (UFPT) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.40% |
| Dec 31, 2025 | 38.59% |
| Sep 30, 2025 | 101.48% |
| Jun 30, 2025 | -24.51% |
| Mar 31, 2025 | 32.73% |
| Dec 31, 2024 | 37.25% |
| Sep 30, 2024 | 16.18% |
| Jun 30, 2024 | 33.03% |
| Mar 31, 2024 | 38.77% |
| Dec 31, 2023 | 36.75% |
| Sep 30, 2023 | 165.93% |
| Jun 30, 2023 | -3.26% |
| Mar 31, 2023 | 34.83% |
| Dec 31, 2022 | 29.97% |
| Sep 30, 2022 | 55.08% |
| Jun 30, 2022 | -13.37% |
| Mar 31, 2022 | 27.06% |
| Dec 31, 2021 | 28.85% |
| Sep 30, 2021 | 8.87% |
| Jun 30, 2021 | -0.97% |
| Mar 31, 2021 | 20.04% |
| Dec 31, 2020 | 19.06% |
| Sep 30, 2020 | 6.04% |
| Jun 30, 2020 | -1.32% |
| Mar 31, 2020 | 20.66% |
| Dec 31, 2019 | 19.39% |
| Sep 30, 2019 | -22.53% |
| Jun 30, 2019 | -44.72% |
| Mar 31, 2019 | 2.10% |
| Dec 31, 2018 | 2.79% |
| Sep 30, 2018 | -46.22% |
| Jun 30, 2018 | 3.37% |
| Mar 31, 2018 | 5.77% |
| Dec 31, 2017 | 4.58% |
| Sep 30, 2017 | 5.92% |
| Jun 30, 2017 | 22.28% |
| Mar 31, 2017 | 2.26% |
| Dec 31, 2016 | -4.18% |
| Sep 30, 2016 | -31.69% |
| Jun 30, 2016 | -22.76% |
| Mar 31, 2016 | -4.22% |
| Dec 31, 2015 | 0.54% |
| Sep 30, 2015 | -26.30% |